SCHEDULE 13G Filed 2026-07-10 Event — SEC 0000921895-26-001796 →

BIOTECHNOLOGY VALUE FUND L P → Pyxis Oncology, Inc. PYXS

Stake: — Shares: — CUSIP: 747324101 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

41 filings by this filer

40 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 4.19

4,172,154 shares short · +28.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $216K

Point72 Asset Mgmt

Other 13D/G Filings on Pyxis Oncology, Inc.

Filed	Form	Filer	Stake	Shares
2026-07-02	SCHEDULE 13G/A	GordonMD Global Investments LP	—	—	view →
2025-04-02	SCHEDULE	Sullivan Lara	11.21%	7,543,007	view →
2023-04-04	SC	Sullivan Lara	—	—	view →

Other Filings by BIOTECHNOLOGY VALUE FUND L P

Filed	Form	Issuer	Stake	Shares
2026-08-04	SCHEDULE 13D	Entera Bio Ltd.	9.99%	9,171,741	view →
2026-07-20	SCHEDULE 13G	Research Alliance Corp IV	—	—	view →
2026-07-16	SCHEDULE 13D/A	XOMA Royalty Corp	—	0	view →
2026-06-29	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	19.70%	8,302,735	view →
2026-06-26	SCHEDULE 13D/A	Kymera Therapeutics, Inc. KYMR	6.30%	2,712,852	view →
2026-06-04	SCHEDULE 13G	Q32 Bio Inc. QTTB	—	—	view →
2026-05-29	SCHEDULE 13G	Research Alliance Corp III RACC	—	—	view →
2026-05-27	SCHEDULE 13G	OnKure Therapeutics, Inc. OKUR	—	—	view →
2026-05-18	SCHEDULE 13D/A	XOMA Royalty Corp XOMAP	—	3,635,758	view →
2026-04-02	SCHEDULE 13D/A	MoonLake Immunotherapeutics MLTX	22.30%	8,302,735	view →
2025-11-24	SCHEDULE	Repare Therapeutics Inc.	24.00%	10,333,600	view →
2025-05-20	SCHEDULE	XOMA Royalty Corp XOMAP	21.60%	2,590,303	view →
2025-01-28	SCHEDULE	XOMA Royalty Corp XOMAP	25.30%	2,983,026	view →
2024-10-08	SC	MoonLake Immunotherapeutics MLTX	—	—	view →
2024-07-19	SC	Inventiva S.A. IVEVF	—	—	view →
2024-01-29	SC	Rain Oncology Inc.	—	—	view →
2024-01-09	SC	Kymera Therapeutics, Inc. KYMR	—	—	view →
2023-12-18	SC	Rain Oncology Inc.	—	—	view →
2023-06-30	SC	MoonLake Immunotherapeutics MLTX	—	—	view →
2022-01-11	SC	Rain Therapeutics Inc.	—	—	view →

Showing 20 of 40

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →